What does SSTI stand for?

inhibitors and those treated with methotrexate and other standard disease modifying medicines showed an increased likelihood for hospitalization with infection in one study and an overall increased risk for skin and soft tissue infection in another.

The spectrum of GGS infections ranged from mild skin and soft tissue infection (34 [46%]) to invasive diseases, including urogenital infection (7 [10%]); lower respiratory tract infection (7 [10%]); pharyngitis (6 [8%]); endocarditis and catheter infection (5 [7%]); and others (14 [19%]), such as peritonitis, pelvic abscess, rectal abscess, and septic arthritis.

ZEVTERA is in the final stage of approval for the treatment of complicated skin and soft tissue infections.

Zyvox is now in Phase III clinical trials and is being studied for the treatment of skin and soft tissue infections, pneumonia, and bacteremia caused by gram-positive bacteria such as methicillin-resistant S.

Scope: * Epidemiological trends and economic impact of key pathogens * Overview of diagnosis and referral patterns * Analysis of present and future unmet needs with outline of key drugs in development for SSTIs * Outline of drivers of treatment choice in both the hospital and the community setting Highlights of this title: Guideline adoption for skin and soft tissue infections (SSTIs) among specialists is fairly strong, but less so among primary care physicians (PCPs).

First detected case of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infection in Italy.

These infections include, pneumonia, skin and soft tissue infections, sepsis (infection in the bloodstream, infected joints, abdominal infections, and osteomyelitis (bone infections).

Methods: A retrospective cohort study of outpatient skin and soft tissue infections due to S aureus in 2003.